SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001420720-22-000049
Filing Date
2022-09-21
Accepted
2022-09-21 08:28:37
Documents
15
Period of Report
2022-09-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ibio-20220916x8k.htm   iXBRL 8-K 37724
2 EX-10.1 ibio-20220916xex10d1.htm EX-10.1 446359
3 EX-99.1 ibio-20220916xex99d1.htm EX-99.1 22576
  Complete submission text file 0001420720-22-000049.txt   695969

Data Files

Seq Description Document Type Size
4 EX-101.SCH ibio-20220916.xsd EX-101.SCH 4011
5 EX-101.DEF ibio-20220916_def.xml EX-101.DEF 3281
6 EX-101.LAB ibio-20220916_lab.xml EX-101.LAB 13580
7 EX-101.PRE ibio-20220916_pre.xml EX-101.PRE 10175
9 EXTRACTED XBRL INSTANCE DOCUMENT ibio-20220916x8k_htm.xml XML 4617
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35023 | Film No.: 221255058
SIC: 2834 Pharmaceutical Preparations